Clinical Trials
45
Active:0
Completed:34
Trial Phases
4 Phases
Phase 1:26
Phase 2:7
Phase 3:10
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials
Phase 1
26 (57.8%)Phase 3
10 (22.2%)Phase 2
7 (15.6%)Not Applicable
2 (4.4%)A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- INSYS Therapeutics Inc
- Target Recruit Count
- 24
- Registration Number
- NCT03827642
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- INSYS Therapeutics Inc
- Target Recruit Count
- 24
- Registration Number
- NCT03827629
- Locations
- 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States
Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain
Phase 2
Completed
- Conditions
- Pain, Postoperative
- Interventions
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2018-10-29
- Lead Sponsor
- INSYS Therapeutics Inc
- Target Recruit Count
- 100
- Registration Number
- NCT03254459
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸Epic Medical Research, Murray, Utah, United States
Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
- First Posted Date
- 2016-09-27
- Last Posted Date
- 2018-02-14
- Lead Sponsor
- INSYS Therapeutics Inc
- Target Recruit Count
- 45
- Registration Number
- NCT02915978
- Locations
- 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Anaheim Clinical Trials, Anaheim, California, United States
Fentanyl Sublingual Spray in Opioid Naive Participants
Phase 1
Completed
- Conditions
- Pharmacology
- Interventions
- First Posted Date
- 2015-12-29
- Last Posted Date
- 2016-03-30
- Lead Sponsor
- INSYS Therapeutics Inc
- Target Recruit Count
- 96
- Registration Number
- NCT02641340
- Locations
- 🇺🇸
Lotus Clinical Research, Inc., Pasadena, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found